Matinas BioPharma Unveils Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
In: Plus Company Updates, 2024-03-25
Zeitungsartikel
Zugriff:
BEDMINSTER: Matinas BioPharma Holdings, Inc. announces positive results from an additional in vivo study in healthy mice with an oral LNC formulation of docetaxel, a well-established chemotherapeutic agent used in [...]
Titel: |
Matinas BioPharma Unveils Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
|
---|---|
Zeitschrift: | Plus Company Updates, 2024-03-25 |
Veröffentlichung: | 2024 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|